CAS: 660847-06-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | HDAC inhibitor REF: IN-DA00FGQGCAS: 660847-06-3 | 97% | To inquire | Tue 21 Jan 25 |
 | N-Acetyl-L-leucylglycyl-N6-acetyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)-L-lysinamide REF: 3D-FA39438CAS: 660847-06-3 | Min. 95% | To inquire | Tue 04 Mar 25 |
Ref: IN-DA00FGQG
| 5mg | 159.00 € | ||
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
N-Acetyl-L-leucylglycyl-N6-acetyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)-L-lysinamide
CAS:660847-06-3
N-Acetyl-L-leucylglycyl-N6-acetyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)-L-lysinamide is a histone deacetylase (HDAC) inhibitor. HDAC inhibitors are used as an antiatherosclerotic and …
Purity:
Min. 95%
Ref: 3D-FA39438
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 4 Mar 2025
